CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
CVI Accepts, published online ahead of print on 7 May 2008
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Zandijk, E.
Right arrow Articles by Cartuyvels, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zandijk, E.
Right arrow Articles by Cartuyvels, R.
Clin. Vaccine Immunol. doi:10.1128/CVI.00022-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

False-positive Platelia Aspergillus galactomannan antigen test for patients treated with amoxicillin-clavulanate

E. Zandijk, A. Mewis, K. Magerman, and R. Cartuyvels*

Department of Internal Medicine, Clinical Laboratory, Virga Jesse Hospital, Hasselt, Belgium

* To whom correspondence should be addressed. Email: reinoud.cartuyvels{at}virgajesse.be.


  Abstract

The Aspergillus galactomannan test is a valuable tool in the diagnosis of invasive aspergillosis. We hereby report a high rate of false positive test results of the Platelia Aspergillus Galactomannan antigen test (BioRad Laboratories) in patients treated with amoxicillin-clavulanate.




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.